A physician-supervised protocol does not end at the last injection
The landmark STEP 1 trial, published in The New England Journal of Medicine, studied the effects of semaglutide for weight loss in people without diabetes
It does not automatically disqualify a provider, but it is part of the context patients should understand before assuming that an online GLP-1 intake equals a full obesity-medicine workup
As a result, it reduces hunger and helps with weight loss
To date, there is only one published human study of BPC-157: a retrospective survey of sixteen people who had it injected into a painful knee, with no control group and no placebo, asked months later whether they felt better [14]
For a broader look at BPC-157 and other peptides in the marketplace, check out the best BPC-157 products for dogs